The terminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal haemoglobinuria

被引：0
|
作者：
Hillmen, P.
Hill, A.
Muus, P.
Duhrsen, U.
Risitano, A. M.
Schubert, J.
Young, N. S.
Schrezenmeier, H.
Szer, J.
Brodsky, R. A.
Socie, G.
Rollins, S. A.
Rother, R. P.
Bell, L.
Luzzatto, L.
机构：
[1] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England
[2] Radboud Univ Med Ctr, Nijmegen, Netherlands
[3] Univ Hosp, Essen, Germany
[4] Med Federico Univ 2, Naples, Italy
[5] Univ Saarland, Sch Med, D-6650 Homburg, Germany
[6] NHLBI, NIH, Bethesda, MD 20892 USA
[7] Inst Klin Transfus & Immunogenet, Helmholtzstr, Germany
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[10] Hosp St Louis, INSERM, Paris, France
[11] Alex Pahrmaceut Inc, Cheshire, CT USA
[12] Ist Toscano Tumori, Florence, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
102
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-ichi
    Kinoshita, Taroh
    Bedrosian, Camille L.
    Valentine, Marye Ellen
    Khursigara, Gus
    Ozawa, Keiya
    Omine, Mitsuhiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 36 - 46
  • [22] Eculizumab for paroxysmal nocturnal haemoglobinuria: catastrophic health expenditure in Nepalese patients
    Adhikari, Sugat
    Sapkota, Surendra
    Shrestha, Suraj
    Karki, Kshitiz
    Shrestha, Anjan
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [23] Eculizumab A Review of its Use in Paroxysmal Nocturnal Haemoglobinuria
    McKeage, Kate
    [J]. DRUGS, 2011, 71 (17) : 2327 - 2345
  • [24] Fibrinogen and Clot Structure Is Affected By Eculizumab in Patients with Paroxysmal Nocturnal Haemoglobinuria
    Macrae, Fraser
    Bowman, Polly
    Linton, Emma
    Peacock-Young, Barnaby
    Clarke, Deborah
    Newton, Darren J.
    McKinley, Claire E.
    Riley, Kathryn
    Copeland, Nicola
    Arnold, Louise
    Griffin, Morag
    Munir, Talha
    Hillmen, Peter
    Richards, Stephen John
    Ariens, Robert
    Hill, Anita
    [J]. BLOOD, 2017, 130
  • [25] ASSESSMENT OF FERRIC OVERLOAD IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA TREATED WITH ECULIZUMAB
    Eduardo Jose, Salido Fierrez
    Piqueras Mercedes, Berenguer
    Perianes Valentin, Cabanas
    Raul, Perez-Lopez
    Faustino, Garcia-Candel
    Juan Jose, Cerezo Manchado
    Ana Maria, Garcia-Hernandez
    Amor Antonia, Melero
    Arnao Maria, Moya
    Marin Amelia, Martinez
    Poveda Elena, Fernandez
    Almenzar Begona, Navarro
    Jose Maria, Moraleda Jimenez
    [J]. HAEMATOLOGICA, 2016, 101 : 263 - 264
  • [26] Eculizumab for paroxysmal nocturnal haemoglobinuria: catastrophic health expenditure in Nepalese patients
    Sugat Adhikari
    Surendra Sapkota
    Suraj Shrestha
    Kshitiz Karki
    Anjan Shrestha
    [J]. Orphanet Journal of Rare Diseases, 18
  • [27] Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
    Alashkar, Ferras
    Vance, Colin
    Herich-Terhuerne, Doerte
    Preising, Nicole
    Duehrsen, Ulrich
    Roeth, Alexander
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (04) : 589 - 596
  • [28] Serologic Response to Meningococcal Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for the Chronic Treatment with the Terminal Complement Inhibitor Eculizumab
    Roeth, Alexander
    Alashkar, Ferras
    Herich-Terhuerne, Doerte
    Elias, Johannes
    Vogel, Ulrich
    Duehrsen, Ulrich
    [J]. BLOOD, 2014, 124 (21)
  • [29] Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
    Ferras Alashkar
    Colin Vance
    Dörte Herich-Terhürne
    Nicole Preising
    Ulrich Dührsen
    Alexander Röth
    [J]. Annals of Hematology, 2017, 96 : 589 - 596
  • [30] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (11) : 1256 - 1264
12345